Comparison of Two Once-Daily Regimens with a Regimen Consisting of Nelfinavir, Didanosine, and Stavudine in Antiretroviral Therapy-Naïve Adults: 48-Week Results from the Antiretroviral Regimen Evaluation Study (ARES)-Reference-Cited by-同舟云学术

Comparison of Two Once-Daily Regimens with a Regimen Consisting of Nelfinavir, Didanosine, and Stavudine in Antiretroviral Therapy-Naïve Adults: 48-Week Results from the Antiretroviral Regimen Evaluation Study (ARES)

Published:2005-10 Issue:5 Volume:6 Page:235-245
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Lowe S.H.,Wensing A.M.J.,Hassink E.A.M.,ten Kate R.W.,Richter C.,Schreij G.,Koopmans P.P.,Juttmann J.R.,van der Tweel I.,Lange J.M.A.,Borleffs J.C.C.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/A686-M37Y-J2PT-E9GJ

Reference29 articles.

1. NOTES AND QUOTES

2. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005)

3. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

4. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced Acute Pancreatitis: An Evidence-Based Classification (Revised);Clinical and Translational Gastroenterology;2023-07-14

2. Nevirapine-Based Regimens in HIV-Infected Antiretroviral-Naive Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials;PLoS ONE;2013-10-07

3. Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field;Clinical Trials;2010-02

4. Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review;Journal of Antimicrobial Chemotherapy;2009-05-28

5. Brief Report: Stavudine but not Didanosine as Part of HAART Contributes to Peripheral Lipoatrophy: A Substudy from the Antiretroviral Regimen Evaluation Study (ARES);HIV Clinical Trials;2007-10